Patients with systemic lupus erythematosus (SLE) face more than double the risk for atherosclerotic plaque progression than healthy control individuals without the condition, but management of ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis — a primary driver of cardiovascular death worldwide — in large mammals, a study suggests.

Researchers from the University of Southern Denmark and Odense University Hospital have studied tissue from patients with atherosclerosis. They found that many of the cells in the diseased tissue ...

Fatty liver disease can cause fatigue and upper-right abdominal pain in early stages. Metabolic dysfunction-associated steatotic liver disease is linked to obesity and type 2 diabetes. Untreated fatty ...

A drug candidate, previously successful at treating severe fatty liver disease, reduces atherosclerosis - a primary driver of cardiovascular death worldwide - in large mammals, a study suggests.

Heart disease is a term that refers to several types of cardiac conditions. Heart attacks are common and affect one person ...